title: Recent safety updates on type 2 diabetes medications: a case report and the evidence for choosing among several available drugs for this patient.
authors.affiliation: Virginia Commonwealth University School of Pharmacy, Richmond, USA. emsisson@vcu.edu
authors.forename: Evan M
authors.initials: EM
authors.lastname: Sisson
authors.forename: Jessica
authors.initials: J
authors.lastname: Mills
authors.forename: Loan
authors.initials: L
authors.lastname: Chin
mesh_terms: D000368:Aged; D003657:Decision Making; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D004347:Drug Interactions; D006333:Heart Failure / Q000150:complications*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D055118:Medication Adherence; D008687:Metformin / Q000009:adverse effects / Q000627:therapeutic use; D019338:Polypharmacy; D012648:Self Care; D045162:Thiazolidinediones / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D008687:Metformin